The proportion of patients with one or more potentially inappropriate medication (PIM) · older people receiving polypharmacy
It is very uncertain whether pharmaceutical care changes the proportion of patients with one or more potentially… compared with usual care (very low certainty).
1 finding from 1 review
The number of potential prescribing omissions (PPOs) · older people receiving polypharmacy
1 finding from 1 review
The proportion of patients with one or more potential prescribing omission (PPO) · older people receiving polypharmacy
It is very uncertain whether pharmaceutical care changes the proportion of patients with one or more potential prescribing… compared with usual care (very low certainty).
1 finding from 1 review
Hospital admissions · older people receiving polypharmacy
1 finding from 1 review
Quality of life · older people receiving polypharmacy
1 finding from 1 review
Rate of decline of serum bilirubin (micromol/L/hr) · neonatal jaundice
1 finding from 1 review
Bilirubin‐induced brain dysfunction (defined as either the pathological finding of deep‐yellow staining of neurons and neuronal necrosis of the basal ganglia and brainstem nuclei or acute or chronic neurological deficit including athetoid cerebral... · neonatal jaundice
1 finding from 1 review
Treatment failure (need to restart phototherapy or exchange transfusion or both) · neonatal jaundice
1 finding from 1 review
Mortality (all cause) · neonatal jaundice
1 finding from 1 review
Cardiovascular mortality · adults with CKD
Antioxidants showed no clear difference in cardiovascular death compared with control (low certainty).
1 finding from 1 review
Death (any cause) · adults with CKD
Antioxidants showed no clear difference in death (any cause) compared with control (moderate certainty).
1 finding from 1 review
CVD · adults with CKD
Antioxidants probably leads to lower cardiovascular disease compared with control (moderate certainty).
1 finding from 1 review
Heart failure · adults with CKD
Antioxidants probably leads to higher heart failure compared with control (moderate certainty).
1 finding from 1 review
Kidney failure · adults with CKD
Antioxidants showed no clear difference in kidney failure compared with control (moderate certainty).
1 finding from 1 review
Change in eGFR · adults with CKD
1 finding from 1 review
Graft loss · adults with CKD
Antioxidants showed no clear difference in graft loss compared with control (moderate certainty).
1 finding from 1 review
Infection · adults with CKD
Antioxidants probably leads to higher infection compared with control (moderate certainty).
1 finding from 1 review
Intervention not reported
Mean BCVA (logMAR) · people with proliferative diabetic retinopathy undergoing vitrectomy
The intervention showed no clear difference in mean BCVA (logMAR) (low certainty).
1 finding from 1 review
Intervention not reported
Early POVCH Â · people with proliferative diabetic retinopathy undergoing vitrectomy
The intervention probably leads to lower early POVCH Â (moderate certainty).
1 finding from 1 review
Intervention not reported
Late POVCH Â · people with proliferative diabetic retinopathy undergoing vitrectomy
The intervention leads to lower late POVCH Â (high certainty).
1 finding from 1 review